The fund owned 91,682 shares of the company's stock after selling 117,350 shares during the period. O Shaughnessy Asset Management LLC's …
Astrazeneca PLC
Astrazeneca stock rose Friday after the company said that its Lynparza drug fared well in clinical trials of its effectiveness as a breast cancer treatment. James Skinner Stock futures retreat again on Friday, looking to …
AstraZeneca Stock
AstraZeneca’s share price has inched marginally lower in London this morning, having shed 0.27 percent to 4,582.50p as of 10:08 GMT. The …
AstraZeneca
Many research firms have provided their ratings on AstraZeneca PLC (NYSE:AZN) where Leerink Partners provided Outperform rating on the stock on 9-Dec-16. Astrazeneca PLC now has a consensus rating of "Buy" …
AstraZeneca PLC
The firm's market capitalization is GBX 53.70 billion. Institutional investors now hold around $9.47 billion or 13.8% in AZN stock. Astrazeneca
AstraZeneca PLC